BANK VONTOBEL/CALL/ABBOTT LABORATORIES/130/0.1/20.12.24 Stock

Warrant

DE000VD3STM0

Real-time Boerse Frankfurt Warrants 04:23:22 2024-05-30 am EDT
0.035 EUR -5.41% Intraday chart for BANK VONTOBEL/CALL/ABBOTT LABORATORIES/130/0.1/20.12.24
Current month-67.54%
1 month-70.16%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-30 0.035 -5.41%
24-05-29 0.037 -2.63%
24-05-28 0.038 -28.30%
24-05-27 0.053 -1.85%
24-05-24 0.054 -8.47%

Real-time Boerse Frankfurt Warrants

Last update May 30, 2024 at 04:23 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Vontobel Vontobel
WKN VD3STM
ISINDE000VD3STM0
Date issued 2024-04-09
Strike 130 $
Maturity 2024-12-20 (205 Days)
Parity 10 : 1
Emission price 0.22
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.28
Lowest since issue 0.035
Spread 0.01
Spread %21.74%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
100.7 USD
Average target price
125.4 USD
Spread / Average Target
+24.46%
Consensus